Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00584168 · ClinicalTrials.gov registry record · Phase 1

Using Dexamethasone After Uvulopalatopharyngoplasty

A Phase 1 study, sponsored by University of Oklahoma.

Completed
Registry status
Phase 1
Development phase
15
Enrollment target

NCT00584168 is a Phase 1 study that has completed, run by University of Oklahoma. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00584168, a Phase 1 study, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
Phase 1
Development phase
15 participants
Enrollment target

Study Summary

This study looks at lessening the pain after a Uvulopalatopharyngoplasty (UPPP) surgery by using Dexamethasone (a corticosteroid).

Interventions

  • DRUG Placebo
  • DRUG Dexamethasone

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2005-03
Est. Completion 2011-12
Phase Phase 1

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT00584168

The ClinicalTrials.gov registry entry for NCT00584168 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT00584168 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00584168 about?

NCT00584168 is a clinical study titled "Using Dexamethasone After Uvulopalatopharyngoplasty". This study looks at lessening the pain after a Uvulopalatopharyngoplasty (UPPP) surgery by using Dexamethasone (a corticosteroid).

What is the current status of trial NCT00584168?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2005-03. Estimated completion is 2011-12.

What interventions are being tested in trial NCT00584168?

The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG).

Who is sponsoring clinical trial NCT00584168?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.